PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40118F18009FDA approval disclosure in direct-to-consumer — Research Triangle Institute

Research Triangle Institute holds $1.4B across 693 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent HHSF223201510002B. Competition previously drew 3 offers. PoP ended Aug 21, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs
Awarding office
Research Triangle Institute
Recipient
Aug 21, 2023
PoP end
$0
Obligated
$651K
Potential
541611
NAICS
B529
PSC
3 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Research Triangle Institute — $90

Contract facts

Federal
Contract number75F40118F18009
Also listed asHHSF223201510002B-75F40118F18009
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentResearch Triangle Institute
CAGE3A730
UEIJJHCMK4NT5N3
NAICS541611
PSCB529
Parent IDIQ / IDVHHSF223201510002B
Place of performanceSILVER SPRING MD
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitationTFTPMC000874B
PoP startSep 11, 2018
PoP end (current)Aug 21, 2023
PoP end (w/ options)Sep 24, 2023
Obligated$0
Current value$651K
Potential value$651K

FDA APPROVAL DISCLOSURE IN DIRECT-TO-CONSUMER AND PROFESSIONAL PRESCRIPTION DRUG PROMOTION is a federal award for Fda Office Of Acq Grant Svcs held by Research Triangle Institute. Estimated value $651K ($0 obligated). Current period of performance ends Aug 21, 2023 (potential Sep 24, 2023). Last award drew 3 bidders. Place of performance: SILVER SPRING MD. Related solicitation TFTPMC000874B.

FDA APPROVAL DISCLOSURE IN DIRECT-TO-CONSUMER AND PROFESSIONAL PRESCRIPTION DRUG PROMOTION

Recompete timing

Public
Past PoP end (1096 days ago)

Current PoP ended Aug 21, 2023 (1096 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Research Triangle Institute$1.4B obligated across 693 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($1.4B) · all agencies · Top 4 shown (93%); remaining ~7% is other agencies.
Department of Health and Human Services (HHS)$869.0M · 62%
Agency for International Development (USAID)$298.1M · 21%
Environmental Protection Agency (EPA)$73.6M · 5%
Department of Education (ED)$56.4M · 4%
Open full company profile

Related awards

Same parent · incumbent
68HERH24F0319
PURPOSE: NEW TASK ORDER [FOLLOW-ON] PROJECT: OIL AND GAS BPA# 68HERD20A0004 CONTRACTOR: R…
$3.4M
Aug 30, 2026
75FCMC21F0064
MEDICARE SHARED SAVINGS PROGRAM ACCOUNTABLE CARE ORGANIZATION (ACO) PROGRAM ANALYSIS AND O…
$93.1M
Aug 31, 2026
75FCMC21F0091
THE DURABLE MEDICAL EQUIPMENT, PROSTHETICS, ORTHOTICS, AND SUPPLIES (DMEPOS) COMPETITIVE B…
$762K
Aug 31, 2026
75D30122C13562
COST EFFECTIVENESS ANALYSIS SERVICES FOR TBESC-III
$708K
Aug 31, 2026
75D30124P19132
DIABETES SIMULATION MODELS
$250K
Aug 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40118F18009?

75F40118F18009 (FDA approval disclosure in direct-to-consumer) is a Fda Office Of Acq Grant Svcs award with a potential value of $651K, currently held by Research Triangle Institute. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40118F18009?

Fda Office Of Acq Grant Svcs awarded 75F40118F18009 to Research Triangle Institute (potential $651K).

Who is the incumbent on 75F40118F18009?

Research Triangle Institute is the incumbent with $1.4B across 693 related awards in SCOUT’s public footprint. The current period of performance ends Aug 21, 2023.

When does Research Triangle Institute’s 75F40118F18009 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 21, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40118F18009